WiseFSulzbergerM. Editorial remarks in Year Book of Dermatology and Syphylology. Chicago: Year Book Publishers, 1993.
2.
HanifinJMRajkaG. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh)1980; 92:44–47.
3.
KangKTianR. Atopic dermatitis. An evaluation of clinical and laboratory findings. Int J Dermatol1987; 26:27–32.
4.
BeltraniVS. The clinical manifestations of atopic dermatitis. In: LeungDYM, ed. Atopic dermatitis: From pathogenesis to treatment. Austin, TX: RG Landes, 1996:1–40.
5.
MarshDG. Allergens and the genetics of allergy. In: SelaM, ed. The antigens. Vol 3. New York: Academic Press, 1975: 271–359.
6.
MarshDGMeyersDABiasWB. The epidemiology and genetics of atopic allergy. N Engl J Med1981; 305:1551–1559.
7.
CocaACookeR. On the classification of the phenomena of hypersensitivity. J Immunol1923; 8:163–182.
8.
IshizakaKIshizakaTHornbrookM. Physicochemical properties of reagenic antibody. J Immunol1966; 97:840–853.
9.
GalliSJ. New concepts about the mast cell. N Engl J Med1993; 328:257–264.
10.
HoffmanDRYamamotoFYGellerBHaddadZ. Specific IgE antibodies in atopic eczema. J Allergy Clin Immunol1975; 55:256–267.
11.
SampsonHAAlbergoR. Comparison of results of prick skin tests, RAST and double-blind placebo-controlled food changes in children with atopic dermatitis. J Allergy Clin Immunol1984; 74:26–33.
12.
RingJ. Atopic dermatitis: A disease of general vasoactive mediator dysregulation.
13.
LebelBVenenciePSauratJ. Anti-IgE induced histamine release from basophils in children with atopic dermatitis. Acta Derm Venereol Suppl (Stockh)1980; 92:57–59.
14.
SullivanT. Drug Allergy. In: MiddletonEJr.ReedCE, eds. Allergy: Principles and practice. St. Louis: Mosby, 1993:1726–1746.
15.
BeltraniVS. The Atopic Skin Symposium, Columbia University, New York; 1990.
JuhlinL. Localization and content of histamine in normal and diseased skin. Acta Derm Venereol Suppl (Stockh)1967;47:383–391.
22.
RuzickaTGluchS. Cutaneous histamine levels and histamine releasibility in the skin in atopic dermatitis and hyper IgE syndrome. Arch Dermatol Res1983; 275:41–44.
23.
HagermarkOWahlgrenC-F. Itch is atopic dermatitis: The role of histamine and other mediators and the failure of antihistamine therapy. Dermatol Ther1996; 1:75–82.
24.
MehlhopPDvandeRijnMGoldbergAB. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A1997; 94:1344–1349.
HanifinJM. Do mast cells play a role in atopic dermatitis? In: KalinerMMetcalfeDD, eds. Mast cells in health and disease. New York: Marcel Dekker, 1992:639–651.
28.
RomagnaniSDelPreteGFMaggiE. Role of interleukins in induction and regulation of human IgE synthesis. Clin Immunol Immunopathol1989; 50:S13–S23.
29.
BoguniewiczMNicolNHLeungDYM. Atopic disease and the skin. In: CharlesworthEN, ed. Cutaneous allergy. Cambridge: Blackwell Science, 1996:209–231.
30.
ThegpenTLangeveld-WildschutEGBihariIC. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: An immunocytochemical study. J Allergy Clin Immunol1996; 97:828–837.
31.
ChanSCKimJWHendersonWRHanifinJM. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol1993; 151:3345–3362.
32.
CooperKDTaylorRSHammerbergC. Abnormal Langerhans' cell differentiation in atopic dermatitis: Increased CD36, CDib, CDic, expression in association with increased autostimulatory capacity. Clin Res1990; 38:835A.
33.
HanifinJM. Atopic dermatitis in infants and children. Pediatric Clin North Am1991; 38:763–789.
34.
RothenbergME. Eosinophil. N Engl J Med1998; 338: 1592–1600.
35.
WahlgrenCFHagermarkOBergstromR. Patients' perception of itch induced by histamine, 44/80, and wool fibers in atopic dermatitis. Acta Derm Venereol Suppl (Stockh)1991; 71:488–494.
36.
LaMotteRH. Psychophysical and neurophysiologic studies of chemically induced cutaneous pain and itch. Prog Brain Res1988;74:331–335.
37.
EngmanMRWeissRSEngmanMEJr. Eczema and environment. Med Clin North Am1936; 20:651–663.
38.
NassifAChanSCStorrsFJHanifinJM. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol1994; 130:1402–1407.
39.
WahlgrenCF. Itch and AD: Clinical and experimental studies. Acta Derm Venereol Suppl (Stockh)1991; 165:1–53.
40.
RingJDarsowUAbeckD. The atopy patch test as a method of studying aeroallergens as triggering factors of atopic dermatitis. Dermatol Ther1996; 1:51–60.
41.
BeltraniVS. The role of dust mites in atopic dermatitis: A preliminary report. Immunol Allergy Clinics1997; 17:431–442.
42.
MorrenMAPrzybillaBBamelisM. Atopic dermatitis: Triggering factors. J Am Acad Dermatol1994; 31:467–473.
43.
HoganDDanakerCMaibachHI. Contact dermatitis: Risk factors and rehabilitation. Semin Dermatol1990; 9:233–246.
44.
JonesSMSampsonHA. The role of allergens in atopic dermatitis. In: LeungDYM, ed. Atopic dermatitis: From pathogenesis to treatment. Austin, TX: RG Landes, 1996:41–65.
45.
KubotaYImayamaSHoriY. Reduction of environmental mites improved atopic dermatitis with positive mite patch test. J Dermatol1992; 19:177–180.
46.
SandaTYasueTOohashiM. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol1992; 89:653–657.
47.
TupkerRADeMonchyJGCoenraadsPJ. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol1996; 97:1064–1070.
48.
ClarkRAFAdinoffAD. Aeroallergen contact can exacerbate atopic dermatitis: Patch tests as a diagnostic tool. J Am Acad Dermatol1989; 21:863–869.
49.
ClarkRAFAdinoffAD. The relationship between positive aeroallergen patch test reactions and aeroallergen exacerbations of atopic dermatitis. Clin Immunol Immunopathol1989;53(Suppl):S132–S140.
50.
YuBSawaiTUeharaM. Immediate hypersensitivity skin reactions to human dander in atopic dermatitis. Arch Dermatol1988; 124:1530–1533.
51.
HauserCPrinsCLacourM. The role of infectious agents in atopic dermatitis. In: LeungDYM, ed. Atopic dermatitis: From pathogenesis to treatment. Austin, TX: RG Landes, 1996:67–112.
52.
WilliamsREAGibsonAGAitchisonTC. Assessment of a contact plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol1990;23:493–501.
53.
BrobergAFaergemannJJohanssonS. Pityrosporon ovale and atopic dermatitis in children and young adults. Acta Derm Venereol Suppl (Stockh)1992; 72:187–192.
BraunsteinWBDeuellBPlatts-MillsTAE. Atopic dermatitis associated with dermatophyte infection and Trichophyton hypersensitivity. Cutis1993; 51:191–192.
56.
PrzybillaBRingJ. Food allergy and atopic eczema. Semin Dermatol1990; 9:220–225.
57.
CrossenJR. Psychological assessment and treatment of patients with atopic dermatitis. Dermatol Ther1996; 1: 94–103.
58.
GianettiAGirolomoniG. Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol1989; 121:681–688.
59.
SteigerTBorelliS. Significance of climatic factors in the treatment of atopic eczema. In: RuzickaTRingJPrzybillaB, eds. Handbook of atopic eczema. Berlin: Springer-Verlag, 1991:415–428.
60.
KemmettDTidmanMJ. The influence of the menstrual cycle and pregnancy on atopic dermatitis. Br J Dermatol1991; 125:59–61.
61.
LangelandTFagertunHELarsenS. Therapeutic effect of loratidine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study. Allergy1994; 49:22–26.
62.
LaRosaMRannoCMusarroIGuglielmoF. Double-blind study of cetirizine in atopic eczema in children. Ann Allergy1994; 73:117–122.
63.
FroschPJSchwanitzHJMacherE. A double-blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis. Arch Dermatol Res1984; 276:36–40.
64.
Berth-JonesJGraham-BrownRAC. Failure of terfenidine in relieving the pruritus of atopic dermatitis. Br J Dermatol1989; 121:635–637.
65.
WahlgrenCFHagermarkOBergstromR. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol1990; 122:545–551.
66.
GeorgalaSSchulpisKHPapaconstantinouEDStratigosJ. Raised beta-endorphin serum levels in children with atopic dermatitis and pruritus. J Dermatol Sci1994; 8:125–128.
67.
HagermarkO. Peripheral and central mediators of itch. Skin Pharmacol Appl Skin Physiol1992; 5:1–8.
68.
LippertUHoerAMollerARamboerI. Role of antigen-induced cytokine release in atopic pruritus. Int Arch Allergy Immunol1998; 116:36–39.
69.
WahlgrenCFLinderTengvall MHagermarkOScheyniusA. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res1995; 287:572–580.
70.
VogelsangMHeyerGHornsteinOP. Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects. Acta Derm Venereol1995; 75:434–436.
71.
SowdenJMBerth-JonesJRossJS. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet1991; 338:137–140.
72.
LawrenceID. Tacrolimus (FK506): Experience in dermatology. Dermatol Ther1998; 5:78–84.
73.
KrutmannJ. Phototherapy for atopic dermatitis. Dermatol Ther1996; 1:24–31.
74.
CarucciJAWashenikKWeinsteinA. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol1998; 134:785–788.
75.
MonroeEW. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. J Am Acad Dermatol1989; 21:135–136.
76.
RustinMHAPoulterL. Chinese herbal therapy in atopic dermatitis. Dermatol Ther1996; 1:83–93.
77.
PickerLJTreerJRFerguson-DarnellB. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T-cells. J Immunol1993; 150:122–136.
78.
HeusserCHBrinkmannV. Immune response and pathophysiology of the allergic reaction. Ther Umsch1994; 51:14–18.
79.
MaurerDStinglG. Abteilung fur Immunodermatologie und infektiose Hautkrankheiren. Wien Klin Wochenschr1993; 105:635–640.
80.
BruijnzeelPLKuijperPHKappA. The involvement of eosinophils in the patch test reaction of aeroallergens in atopic dermatitis: Its relevance for the pathogenesis of atopic dermatitis. Clin Exp Allergy1993; 23:97–109.
81.
LeungDYM. Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic disease. J Allergy Clin Immunol1995; 96:302–318.
82.
LeungDYMSchneebergerEESiraganianRP. The presence of IgE on monocytes/macrophages infiltrating the skin lesions of atopic dermatitis. Clin Immunol Immunopathol1987; 42:100–205.
83.
KisslingSWuthrichB. Sites, types of manifestations and micromanifestations of atopic dermatitis in young adults. A personal follow-up 20 years after diagnosis in childhood. Hautarzt1994; 45:368–371.
84.
SvenssonA. Diagnosis of atopic skin disease based on clinical criteria. Kristianstad pg. 68.
85.
BreitR. Neurodermatitis (Dermatitis atopica) im kindesalter. Z Hautkr1977;(Suppl 2):72–82.
86.
RookAWilkinsonDSEblingFJGChampionRH. Textbook of dermatology, 4th Ed.Oxford: Blackwell Scientific, 1996:403.
87.
SchmunesEKeilJE. Occupational dermatitis in South Carolina: A descriptive analysis of cost variables. J Am Acad Dermatol1983; 9:861–866.
88.
HoganDDakerCMaibachHI. Contact dermatitis: Risk factors and rehabilitation. Semin Dermatol1990; 9:233–246.
89.
WilhelmKPMaibachHI. Factors prediposing to cutaneous irritation. Dermatol Clin1990; 8:17–22.
90.
WernerYLindbergM. The water-binding capacity of stratum corneum in non-eczematous skin of atopic eczema. Acta Derm Venereol1982; 62:334–337.
91.
WernerYLindbergM. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol1985; 65:102–105.
92.
SvenssonA. A diagnostic tool for atopic dermatitis based on clinical criteria. Acta Derm Venereol1985; 114:52–57.
93.
WhitfieldA. On the white reaction in dermatology. Br J Dermatol1938; 50:71–76.
94.
UeharaMOfujiS. Abnormal vascular reactions in atopic dermatitis. Arch Dermatol1977; 113:627–629.